202 related articles for article (PubMed ID: 28004205)
1. Vascular alterations after photodynamic therapy mediated by 5-aminolevulinic acid in oral leukoplakia.
Rosin FC; Barcessat AR; Borges GG; Ferreira LG; Corrêa L
Lasers Med Sci; 2017 Feb; 32(2):379-387. PubMed ID: 28004205
[TBL] [Abstract][Full Text] [Related]
2. Effect of 5-ALA-mediated photodynamic therapy on mast cell and microvessels densities present in oral premalignant lesions induced in rats.
Rosin FC; Barcessat AR; Borges GG; Corrêa L
J Photochem Photobiol B; 2015 Dec; 153():429-34. PubMed ID: 26562807
[TBL] [Abstract][Full Text] [Related]
3. Expression of Bak and Bak/Mcl-1 ratio can predict photodynamic therapy outcome for oral verrucous hyperplasia and leukoplakia.
Yu CH; Chen HM; Lin HP; Chiang CP
J Oral Pathol Med; 2013 Mar; 42(3):257-62. PubMed ID: 22974427
[TBL] [Abstract][Full Text] [Related]
4. Treatment of oral leukoplakia with photodynamic therapy: A pilot study.
Selvam NP; Sadaksharam J; Singaravelu G; Ramu R
J Cancer Res Ther; 2015; 11(2):464-7. PubMed ID: 26148619
[TBL] [Abstract][Full Text] [Related]
5. Effect of topical 5-ALA mediated photodynamic therapy on proliferation index of keratinocytes in 4-NQO-induced potentially malignant oral lesions.
Barcessat AR; Huang I; Rosin FP; dos Santos Pinto D; Maria Zezell D; Corrêa L
J Photochem Photobiol B; 2013 Sep; 126():33-41. PubMed ID: 23892188
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
Chen HM; Yu CH; Tu PC; Yeh CY; Tsai T; Chiang CP
Lasers Surg Med; 2005 Aug; 37(2):114-22. PubMed ID: 16037967
[TBL] [Abstract][Full Text] [Related]
7. Effect of photodynamic therapy using 5-aminolevulinic acid on 4-nitroquinoline-1-oxide-induced premalignant and malignant lesions of mouse tongue.
Ma G; Ikeda H; Inokuchi T; Sano K
Oral Oncol; 1999 Jan; 35(1):120-4. PubMed ID: 10211320
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia.
Sieroń A; Adamek M; Kawczyk-Krupka A; Mazur S; Ilewicz L
J Oral Pathol Med; 2003 Jul; 32(6):330-6. PubMed ID: 12787039
[TBL] [Abstract][Full Text] [Related]
9. Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid.
Kübler A; Haase T; Rheinwald M; Barth T; Mühling J
Int J Oral Maxillofac Surg; 1998 Dec; 27(6):466-9. PubMed ID: 9869290
[TBL] [Abstract][Full Text] [Related]
10. A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia.
Wong SJ; Campbell B; Massey B; Lynch DP; Cohen EEW; Blair E; Selle R; Shklovskaya J; Jovanovic BD; Skripkauskas S; Dew A; Kulesza P; Parimi V; Bergan RC; Szabo E
Oral Oncol; 2013 Sep; 49(9):970-976. PubMed ID: 23845699
[TBL] [Abstract][Full Text] [Related]
11. Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia.
Lin HP; Chen HM; Yu CH; Yang H; Wang YP; Chiang CP
J Oral Pathol Med; 2010 Sep; 39(8):624-30. PubMed ID: 21054548
[TBL] [Abstract][Full Text] [Related]
12. Sufficient PpIX production for PDT even with short contact time of topically applied 5-ALA in rabbit tongues.
Oura T; Tanaka H; Morimoto Y; Masumoto K; Kohno E; Hirano T; Katou F; Hashimoto K
Lasers Med Sci; 2008 Oct; 23(4):355-60. PubMed ID: 17885797
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy mediated by 5-aminolevulinic acid suppresses gliomas growth by decreasing the microvessels.
Yi W; Xu HT; Tian DF; Wu LQ; Zhang SQ; Wang L; Ji BW; Zhu XN; Okechi H; Liu G; Chen QX
J Huazhong Univ Sci Technolog Med Sci; 2015 Apr; 35(2):259-264. PubMed ID: 25877362
[TBL] [Abstract][Full Text] [Related]
14. Application of 5-aminolevulinic acid-mediated Waterlase-assisted photodynamic therapy in the treatment of oral leukoplakia.
Ou J; Gao Y; Li H; Ling T; Xie X
Sci Rep; 2022 Jun; 12(1):9391. PubMed ID: 35672359
[TBL] [Abstract][Full Text] [Related]
15. Topical methotrexate pretreatment enhances the therapeutic effect of topical 5-aminolevulinic acid-mediated photodynamic therapy on hamster buccal pouch precancers.
Yang DF; Lee JW; Chen HM; Hsu YC
J Formos Med Assoc; 2014 Sep; 113(9):591-9. PubMed ID: 24811932
[TBL] [Abstract][Full Text] [Related]
16. The combination of photodynamic therapy and fractional CO
Yao Y; Shen X; Shi L; Tang G; Wu L
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101597. PubMed ID: 31707101
[TBL] [Abstract][Full Text] [Related]
17. Application of fractal dimension analysis and photodynamic diagnosis in the case of differentiation between lichen planus and leukoplakia: A preliminary study.
Jurczyszyn K; Kazubowska K; Kubasiewicz-Ross P; Ziółkowski P; Dominiak M
Adv Clin Exp Med; 2018 Dec; 27(12):1729-1736. PubMed ID: 30085425
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch precancerous lesions by topical 5-aminolevulinic acid-mediated photodynamic therapy.
Hsu YC; Yang DF; Chiang CP; Lee JW; Tseng MK
Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):310-8. PubMed ID: 23200011
[TBL] [Abstract][Full Text] [Related]
19. Differences in the response of normal oral mucosa, oral leukoplakia, oral squamous cell carcinoma-derived mesenchymal stem cells, and epithelial cells to photodynamic therapy.
Guo Q; Ji X; Zhang L; Liu X; Wang Y; Liu Z; Jin J; Han Y; Liu H
J Photochem Photobiol B; 2024 Jun; 255():112907. PubMed ID: 38677259
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of photodynamic therapy for oral leukoplakia: a retrospective study of 50 patients.
Wang Y; Tang H; Wang K; Zhao Y; Xu J; Fan Y
BMC Oral Health; 2024 Jan; 24(1):9. PubMed ID: 38172857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
